⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZVRA News
Zevra Therapeutics, Inc. Common Stock
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
globenewswire.com
ZVRA
Zevra Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
ZVRA
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
globenewswire.com
ZVRA
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
prnewswire.com
ZVRA
Zevra Therapeutics, Inc. (ZVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA